Equities

Hikal Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Hikal Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)213.52
  • Today's Change3.04 / 1.44%
  • Shares traded6.19m
  • 1 Year change-38.70%
  • Beta1.6122
Data delayed at least 15 minutes, as of Feb 13 2026 10:26 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Hikal Ltd (HIKAL:NSI) closed at 213.52, 20.39% above the 52 week low of 177.35 set on Feb 06, 2026.
52-week range
Today
177.35Feb 06 2026456.75Apr 16 2025
Open210.00
High219.84
Low205.80
Bid213.52
Offer214.90
Previous close210.48
Average volume4.70m
Shares outstanding123.30m
Free float38.12m
P/E (TTM)259.88
Market cap26.33bn INR
EPS (TTM)0.8216
INR
Annual div (ADY)1.00
INR
Annual div yield (ADY)0.47%
Div ex-dateSep 02 2025
Div pay-dateOct 23 2025
Next div ex-dateFeb 17 2026
Next div pay-dateMar 12 2026
Data delayed at least 15 minutes, as of Feb 13 2026 10:26 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.